Mutual Fund Performance Analysis – Franklin Pharma Fund (Growth)
Scheme Objective:
The fund is aimed at generating long term capital appreciation by investing in Pharmaceticals / Life Sciences Sector.
Type of Scheme: Open Ended Equity Scheme – Growth Option
Scheme Inception Date: March, 1999
SIP Plans: Available
Minimum Investment Amount: Rs 5000
Entry Load:NIL
Exit Load: NIL if the amount is redeemed after 1 year.
1% if the amount is redeemed between 0 to 1 year
Latest NAV: 64.97 (as on November, 12, 2010)
52 week high: 65.75 (as on November, 10, 2010)
52 week low: 43.91 (as on November, 19, 2009)
Previous Returns: (as on November 12, 2010)
3 Months – 13.75%
6 Months – 19.61%
1 Year – 48.04 %
3 Years – 33.73 %
5 Years – 23.01 %
Since Inception – 17.46%
Portfolio of Companies:
- Dr Reddys Laboratories Limited
- Cadila Healthcare Limited
- IPCA Laboratories Limited
- Piramal Healthcare limited
- Torrent Pharmaceuticals Limited
- Cipla Limited
- Lupin Limited
- Apollo Hostpitals Enterprise Limited
- Ranbaxy Laboratories Limited
- Pfizer Limited
Performance Report:
The scheme has invested more than 88% of the funds in Pharma Equity Stocks. The rest of around 11% is been holded as Cash and equivalents. The fund has invested in around 28 stocks with an expense ratio of 2.46.
The market cap for the fund is more than 12,000 crores with price per earnings ratio of 28.44.
This fund has generated consistent returns for the past years and also since inception. Looking at the good returns and the performance of the scheme, medium risk investors can choose to invest in this scheme on a long term basis.
Happy Investing !!
Disclaimer:
“Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the Scheme will be achieved. Please read the Statement of Additional Information and Scheme Information Document carefully before investing”.
“In Mutual Funds, the past performance is not guaranteed in future”.
The information contained in this website has been obtained from sources considered to be authentic and reliable. However, InvestMutualfunds.net is not responsible for any error or inaccuracy or for any losses suffered on account of information.
